Back to PTCT
UBS Group AG PTCT Position History
PTC Therapeutics, Inc. • Healthcare
Quarters held
18
Latest value
$21.6M
Q3 2026
Peak value
$99.2M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $242K |
| Q3 2025 | $26.7M |
| Q3 2025 | $835K |
| Q3 2025 | $11K |
| Q4 2025 | $722K |
| Q4 2025 | $35.1M |
| Q4 2025 | $653K |
| Q4 2025 | $36.8M |
| Q1 2026 | $125K |
| Q1 2026 | $92.8M |
| Q1 2026 | $82K |
| Q2 2026 | $944K |
| Q2 2026 | $18.9M |
| Q2 2026 | $1.6M |
| Q3 2026 | $126K |
| Q3 2026 | $99.2M |
| Q3 2026 | $937K |
| Q3 2026 | $21.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $21.6M | 333.1K | — | — |
| Q3 2026 | $937K | 14.5K | — | — |
| Q3 2026 | $99.2M | 1.53M | — | — |
| Q3 2026 | $126K | 2.0K | — | — |
| Q2 2026 | $1.6M | 19.3K | — | — |
| Q2 2026 | $18.9M | 231.5K | — | — |
| Q2 2026 | $944K | 11.6K | — | — |
| Q1 2026 | $82K | 1.2K | — | — |
| Q1 2026 | $92.8M | 1.36M | — | — |
| Q1 2026 | $125K | 1.8K | — | — |
| Q4 2025 | $36.8M | 484.6K | — | — |
| Q4 2025 | $653K | 8.6K | — | — |
| Q4 2025 | $35.1M | 461.9K | — | — |
| Q4 2025 | $722K | 9.5K | — | — |
| Q3 2025 | $11K | 173 | — | — |
| Q3 2025 | $835K | 13.6K | — | — |
| Q3 2025 | $26.7M | 434.5K | — | — |
| Q3 2025 | $242K | 3.9K | — | — |
Other funds holding PTCT
$784.3M
$683M
$631.9M
$628.6M
$615.3M
$588.4M
$527.8M
$479.2M